Korean shipyards clinched orders totaling 1.54 million compensated gross tons (CGTs) to build 18 ships, accounting for 62 percent of the global total of 2.49 million CGTs last month, according to London-based Clarksons Research Services.
Matica Biotechnology, a US subsidiary of CHA Biotech, has appointed Laura Parks as EVP of commercial operations and Heather Sugrue as VP of alliance management to enhance its cell and gene therapy contract manufacturing capabilities.
Korean pharmaceutical companies are making big bets on the cell and gene therapy market, the sector that many consider to be the next game-changer in the global pharma world.
Matica Biotechnology, a wholly-owned subsidiary of CHA Biotech, celebrated the completion of a cell and gene therapy manufacturing facility in College Station, Texas, Tuesday.
Korea JoongAng Daily Sitemap
